Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mikkel Carstensen Gjelstrup
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients With Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel
PLoS ONE
Multidisciplinary
Related publications
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients With Multiple Sclerosis
PLoS ONE
Multidisciplinary
Evaluating Biomarkers of Neuronal Degeneration and Neuroinflammation in CSF of Patients With Multiple Sclerosis–osteopontin as a Potential Marker of Clinical Severity
Journal of the Neurological Sciences
Neurology
Imaging Axonal Degeneration and Repair in Preclinical Animal Models of Multiple Sclerosis
Frontiers in Immunology
Allergy
Immunology
Diffusion Tensor-Mri Evidence for Extra-Axonal Neuronal Degeneration in Caudate and Thalamic Nuclei of Patients With Multiple Sclerosis
American Journal of Neuroradiology
Medicine
Nuclear Medicine
Neurology
Imaging
Radiology
Role of Interlekin-35 as a Biomarker in Patients With Newly Diagnosed Hashimoto’s Thyroiditis
Endocrine Regulations
Endocrinology
Metabolism
Diabetes
CSF Β-Amyloid Predicts Prognosis in Patients With Multiple Sclerosis
Multiple Sclerosis
Neurology
Serum Metallothionein in Newly Diagnosed Patients With Childhood Solid Tumours.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Circulating miR-150 in CSF Is a Novel Candidate Biomarker for Multiple Sclerosis
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Serum Levels of OPG, RANKL and RANKL/OPG Ratios in Newly-Diagnosed Patients With Multiple Myeloma. Clinical Correlations
Haematologica
Hematology
